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Abstract
 
Interferon-producing cells (IPCs) secrete high levels of type I interferon in response to certain
viruses. The lack of lineage markers, the expression of major histocompatibility complex (MHC)
class II and the capacity to stimulate allogeneic T cells have led these cells to be classified as a
subset of dendritic cells (DCs), called plasmacytoid DCs (PDCs). However, the role of IPCs/
PDCs in initiating primary immune responses remains elusive. Here we examined the antigen
presenting capacity of murine IPCs in antigen specific systems. While CD8
 
 
 
 
 
 and CD11b
 
 
 
DCs induced logarithmic expansion of naive CD4 and CD8 T cells, without conferring T
helper commitment at a first encounter, primary IPCs lacked the ability to stimulate naive T
cells. However, when antigen-experienced, nonpolarized T cells expanded by classical DC sub-
sets, were restimulated by IPCs, they proliferated and produced high amounts of IFN-
 
 
 
. These
data indicate that IPCs can effectively stimulate preactivated or memory-type T cells and exert
an immune-regulatory role. They also suggest that expansion of naive T cells and acquisition of
effector function during antigen-specific T cell responses may involve different antigen-present-
ing cell (APC) types. Independent and coordinated control of T cell proliferation and differenti-
ation would provide the immune system with greater flexibility in regulating immune responses.
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Introduction
 
Natural IFN-producing cells (IPCs)
 
*
 
 were originally iden-
tified in humans as a small subset of blood leukocytes spe-
cialized in the secretion of high levels of type I IFN in re-
sponse to viruses (1–4).
The absence of lineage markers, the expression of MHC
class II molecules, the acquisition of a Dendritic Cell (DC)-
like morphology upon activation, as well as their presence
in secondary lymphoid organs, led to the concept of hu-
man IPCs being a distinct subset of DCs (1). This idea was
also supported by the evidence that viruses, bacterial prod-
ucts or T cell contact can trigger in IPCs a developmental
pathway closely resembling the maturation process of a
genuine DC (1, 2). Human IPCs undergoing activation
gain some T cell stimulatory function in allogeneic mixed
lymphocyte reactions (MLRs; reference 5). However, due
to the low frequency of antigen-specific T cells, the capac-
ity of IPCs to present antigen to naive T cells, an essential
requisite to fulfill the definition of DC (6, 7), has not yet
been fully elucidated.
Recent studies have identified the murine counterpart of
human IPCs. In mouse spleen and lymph nodes, IPCs are a
CD11c low, Ly6C/G
 
 
 
 CD11b
 
 
 
 cell population (8–10).
These phenotypical features allow them to be distin-
guished from other DC subsets, as classical DCs express
high levels of CD11c, are either CD11b
 
 
 
 or CD8
 
 
 
 
 
, and
lack Ly-6G/C, at least in an immature state (7).
Here we have examined the capacity of murine IPCs to
present antigens to naive CD4
 
 
 
 and CD8
 
 
 
 T cells, as com-
pared with the classical CD11b
 
 
 
/CD8
 
 
 
 
 
 and CD11b
 
 
 
/
CD8
 
 
 
 
 
 DC subsets (1). IPCs failed to stimulate a strong
proliferation of naive T cells even after in vivo viral stimu-
lation, questioning their belonging to the DC system (11).
However, IPCs could still promote proliferation of anti-
gen-primed T cells, suggesting that they can exert some ba-
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*
 
Abbreviations used in this paper:
 
 DC, dendritic cell; HEL, hen egg
lysozyme; IPC, IFN-producing cell; VSV, vesicular stomatitis virus.T
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sic APC function for memory-type T cells. In our system,
CD4 T cells expanded by classical DCs remained largely
nonpolarized, preserving a high capacity for IL-2 produc-
tion. These antigen-primed, nonpolarized T cells (12),
when restimulated by IPCs, not only efficiently prolifer-
ated, but also differentiated to a Th1 effector type.
Together, these results are consistent with a model in
which immune responses are regulated by a network of dif-
ferent APCs, each having distinct roles in controlling pro-
liferation and differentiation of antigen-specific naive or
memory T cells.
 
Materials and Methods
 
Media and Reagents.
 
Media were used as described previously
(4, 5). Influenza virus PR8 was grown in MDCK cells, purified
by gradient centrifugation with 20% sucrose and resuspended in
PBS at a titer of 7.4 
 
 
 
 10
 
7
 
 PFU/ml as determined by MDCK
plaque assay. PR8 was used at 1 MOI. Recombinant vesicular
stomatitis virus (VSV) was grown on BHK cells. The titer of clar-
ified virus-containing supernatant was 4 
 
 
 
 10
 
9
 
 PFU/ml as deter-
mined by plaque assay using BHK cells. The IL-12p70 ELISA kit
was obtained from R&D Systems. CpG ODN 1826 (5
 
 
 
-tccat-
gacgttcctgacgtt-3
 
 
 
) was obtained from Operon Technologies.
 
Mice.
 
WT-mHEL (hen egg lysozyme)
 
 
 
mice express mem-
brane-bound HEL under the I-E promoter and are backcrossed
to the B10.BR strain. CD4
 
 
 
 T cells from the 3A9 TCR trans-
genic mouse recognize the HEL peptide 48–62 in the context of
I-A
 
k
 
 (13). HY-specific TCR transgenic mice recognize the HY
male antigen restricted to MHC class I H-2D
 
b
 
. B6 and 129X1/
SvJ mice were obtained from The Jackson Laboratory. All mice
used in experiments were 6–12 wk in age. Handling of mice and
experimental procedures were conducted in accordance with in-
stitutional guidelines for animal care and use. Mice were main-
tained at the Washington University small animal facility. For in
vivo stimulation of IPCs, mice were infected with 2 
 
 
 
 10
 
8
 
 PFU
of VSV intravenously and killed after 9 to 12 h.
 
Preparation and Culture of Cells.
 
Primary splenic IPCs and
DCs, were preenriched by magnetic sorting with CD11c micro-
beads (Miltenyi Biotec) after collagenase treatment of disrupted
spleens. Cells were then stained with anti-Ly-6G/C-PE (RB6–
8C5), anti-CD11b-FITC, and biotinylated anti-CD11c (BD Bio-
sciences) followed by Streptavidin-APC (Molecular Probes) and
sorted into CD11c
 
 
 
/CD11b
 
 
 
/Ly-6G/C
 
 
 
, CD11c
 
 
 
/CD11b
 
 
 
/
Ly-6G/C
 
 
 
, and CD11c
 
 
 
/CD11b
 
 
 
/ Ly-6G/C
 
 
 
 cells (purity
 
 
 
98%) on a MoFlo cytometer. CD4
 
 
 
 T cells were magnetically
isolated with CD4-dynabeads (Dynal) from pooled spleens and
lymph nodes of 3A9 TCR transgenic mice (90% purity, 
 
 
 
2%
MHC class II
 
 
 
 cells). CD4-beads were subsequently detached
(DETACHaBEAD; Dynal). 60 to 90% of CD4
 
 
 
 cells stained
positive with the 1G12 anti-clonotype monoclonal antibody.
CD8 T cells were isolated from pooled spleens and lymph nodes
of female homozygous HY-specific TCR transgenic mice using
CD8
 
 
 
 microbeads (Miltenyi Biotec, purity 
 
 
 
90%).
 
T Cell Assays.
 
IPCs or DCs freshly isolated or cultured over-
night with PR8 (1 MOI), were irradiated (3,000 rad), serially di-
luted, and cocultured with naive CD4 3A9 T cells (10
 
4
 
/well) or
naive CD8 HY-specific TCR transgenic T cells (5 
 
 
 
 10
 
4
 
/well)
for 72 h. H
 
3
 
-thymidine was added in the last 18 h of culture. 3A9
hybridoma T cells were added to APCs at 10
 
5
 
/well and cultured
for 20 h. Hybridoma reactivity was determined by IL-2 secretion.
IL-2 was measured in supernatants as proliferative response of the
IL-2 dependent cell line CTLL. For T cell polarization experi-
ments, naive CD4 3A9 T cells were cocultured with different
DC populations (2 
 
 
 
 10
 
4
 
 T cells, 2 
 
 
 
 10
 
4
 
 DC, 100 
 
 
 
l medium
per well) in 96-well flat bottom plates for 5–7 d. Cells were re-
stimulated with 100 nM PMA and 0.5 
 
 
 
g/ml ionomycin (Sigma-
Aldrich) for 6 h. Monensin (2 
 
 
 
g/ml; Sigma-Aldrich) was added
in the last 4 h. Cells were fixed, permeabilized, and stained intra-
cellularly with anti–IFN-
 
 
 
-FITC, anti–IL-2-APC, and anti–IL-
4-PE (BD Biosciences). 3A9 T cells initially stimulated with
splenic CD11b
 
 
 
 DCs were expanded with 50 U/ml IL-2 for
9–10 d. They were then collected for RNA preparation, stained
for IL-12R
 
 
 
 (BD Biosciences) and IL-18R
 
 
 
 (R&D Systems) ex-
pression, and restimulated with freshly isolated APCs in graded
numbers for proliferation experiments or at 1:1 ratio (2 
 
 
 
 10
 
4
 
)
for polarization experiments. Antibodies against IL-18R
 
 
 
 (R&D
Systems), IFN-
 
 
 
 (PBL Biomedical Laboratories), and/or IL-12
(TOSH) were used to neutralize cytokine activity.
 
Flow Cytometry.
 
Magnetically enriched splenic DCs were
stained with anti-Ly-6G/C-PE and biotinylated anti-CD11c
plus Streptavidin–APC and analyzed for expression of CD40,
CD80, CD86, I-A
 
k
 
, and H-2D
 
b
 
 using FITC-labeled antibodies
(BD Biosciences). Membrane-bound HEL was detected with
FITC-labeled F10.6.6 monoclonal antibody and the 48–62
HEL peptide bound to I-A
 
k
 
 was detected using the Aw3.18
monoclonal antibody.
 
Chemotaxis Assay.
 
Chemotaxis of 3A9 T cells was measured
in a 2 h transwell migration assay using 24-well Costar transwell
chambers (5 
 
 
 
 pore size; Corning). Recombinant mCCL19 was
obtained from PeproTech).
 
Type I IFN Bioassay.
 
Type I IFN was measured by evaluat-
ing the inhibition of proliferation of murine BW 5147 T cell
lymphoma cells with reference to a standard curve with recombi-
nant murine IFN-
 
 
 
 (Biosource International). The lower detec-
tion limit was 10 U/ml IFN-
 
 
 
. In initial experiments bioassay re-
sults were confirmed by measuring IFN-
 
 
 
 by ELISA in parallel
(mouse IFN-
 
 
 
 ELISA kit; PBL Biomedical Laboratories). Briefly,
cell culture supernatants and IFN-
 
 
 
 standard were serially diluted
in 96-well round-bottom plates and 5 
 
 
 
 10
 
3
 
 BW 5147 cells were
added per well. After 36 h of incubation cells were pulsed with
H
 
3
 
-Thymidine and incorporation was measured after 8 h.
 
RT-PCR and Primers.
 
RNA extraction and cDNA synthesis
were performed according to standard protocols. The following
specific primers were used: IL-12R
 
 
 
1
 
: 5
 
 
 
-gccaacattaagttcttggtg-
3
 
 
 
, 5
 
 
 
-attcttggggttcttggaggc-3
 
 
 
; IL-12R
 
 
 
2
 
: 5
 
 
 
-gggagtacatagtg-
gaatgga-3
 
 
 
, 5
 
 
 
-gcgtcggtactgaatttcgca-3
 
 
 
; IL-23R 5
 
 
 
-tgaaagagac-
cctacatcccttga-3
 
 
 
, 5
 
 
 
-cagaaaattggaagttgggatatgtt-3
 
 
 
; IL-12p40: 5
 
 
 
-
gacacgcctgaagaagatgac-3
 
 
 
, 5
 
 
 
-gccattccacatgtcactgc-3
 
 
 
; IL-12p35:
5
 
 
 
-atgatgaccctgtgccttgg-3
 
 
 
, 5
 
 
 
-cctttggggagatgagatgt-3
 
 
 
; IL-23p19:
5
 
 
 
-tggcatcgagaaactgtgaga-3
 
 
 
, 5
 
 
 
-tcagttcgtattggtagtcctgtta-3
 
 
 
; 
 
 
 
-actin:
5
 
 
 
-ggagaagagctatgagctgcct-3
 
 , 5 -gtggtaccaccagacaacact-3 . PCR
conditions: 5 min, 94 C; 30 s, 94 C; 30 s annealing; 60 s 72 C
(40 cycles;  -actin: 30 cycles), and 5 min final extension at 72 C.
The annealing temperature was 62 C for IL-12R 1 and IL-
12R 2, 60 C for IL-23R, IL-12p35, IL-23p19, and 55 C for IL-
12p40. The PCR products were analyzed on 1.5% Nusieve 3:1
(BioWhitaker) agarose gels.
Results
Primary IPCs Are Inefficient in Expanding Antigen-specific
Naive CD4 T Cells. To examine the antigen-presenting
function of primary IPCs to naive CD4 T cells we used, asT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
901 Krug et al.
a model, mHEL transgenic mice, which express membrane
bound HEL as antigen, and CD4  T cells from 3A9 TCR-
transgenic mice, that recognize the HEL peptide 48–62 in
the context of MHC class II I-Ak molecules.
CD11c  cells from spleens of mHEL mice were pre-
pared, and IPCs as well as CD11b  and CD11b CD8  
DCs were sorted at high purity ( 98%, not shown) and
analyzed for mHEL expression by flow cytometry. All sub-
sets expressed substantial levels of HEL antigen at the cell
surface (Fig. 1 A). We tested the ability of each subset to
stimulate naive CD4  T cells derived from 3A9 TCR
transgenic mice in vitro. As shown in Fig. 1 B, IPCs did
not induce proliferation of HEL-specific T cells, as com-
pared with other DCs.
To test whether the antigen presenting function in-
creased with IPC activation, IPCs and other DCs were
sorted and incubated with influenza virus for 12 h before
coculture with HEL-specific T cells in vitro. Viral stimula-
tion of IPCs was sufficient to induce high secretion of type
I IFN (insert to Fig. 1 B), but their T cell stimulatory ca-
pacity was only minimally increased. Other DC subsets
stimulated T cell proliferation 10- to 50-fold more effi-
ciently than IPCs, and incubation with influenza virus fur-
ther increased their T cell stimulatory capacity.
In vitro activation of IPCs may not be sufficient to reveal
their T cell stimulatory function, and in vivo viral infec-
tions might provide more complex and integrated signals,
which can be essential to this task. Thus, we tested the an-
tigen presenting function of IPCs stimulated in vivo with
VSV. It has been previously shown, that 9 to 12 h after
VSV infection, IPCs are activated and secrete IFN-  (14).
We therefore infected mHEL transgenic mice with VSV,
and, after 12 h, sorted IPCs and DC subsets, analyzed their
surface expression of MHC class II and costimulatory mol-
ecules (Fig. 1 C), as well as their ability to stimulate HEL-
specific naive T cells (Fig. 1 D). Upon VSV infection, IPCs
increased cell surface expression of CD40, CD80, MHC
class II, and especially CD86 as compared with IPCs from
Figure 1. HEL expression and antigen presentation to HEL-specific naive CD4 T cells and 3A9 T cell hybridoma by primary mHEL-transgenic DCs
and IPCs. (A) IPCs and Ly-6G/C  DCs from the mHEL mouse were stained with an antibody specific for HEL to measure antigen expression at the cell
surface (gray histograms). Open histograms indicate staining with control antibody. (B) Proliferative response of HEL-specific naive 3A9 CD4 T cells
(104) cultured with graded numbers of purified IPCs (open symbols), CD11b (black filled symbols), and CD8   (gray filled symbols) DCs derived from
mHEL mice. IPCs and DCs were untreated (circles) or treated (squares) in vitro for 12 h with PR8 (1 MOI) before addition of T cells. Supernatants were
then collected and type I IFN production was measured (insert to B). Proliferation was measured after 72 h. (C) Expression of costimulatory molecules,
MHC class II and HEL48–62/IAk specific complexes in IPCs and DCs derived from mHEL-mice. Mice were either uninfected or challenged with VSV
for 12 h. MFI for IPCs and Ly-6G/C  DCs are indicated. (D) Proliferation of 3A9 naive CD4 T cells cocultured with graded numbers of IPCs or DCs
purified ex vivo from mHEL mice uninfected or infected with VSV (intravenous, 2   108 PFU) 12 h before. (E and F) HEL-specific 3A9 cell hybridoma
T cells (105) were cocultured with graded numbers of IPCs and DCs sorted from mHEL mice and stimulated in vitro with influenza virus PR8 (E) or ac-
tivated in vivo by VSV infection (F). Supernatants were collected after 48 h and the IL-2 produced upon activation was measured as proliferation of
CTLL cells after 20 h.T
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902 Interferon-producing Cells Stimulate Memory-type T Cells
uninfected mice (Fig. 1 C). Careful analysis of CD11c ex-
pressing cells, after viral infection, failed to show changes in
the expression of the cell surface markers used for IPC
identification (CD11b and Ly6C/G), although Ly6C/G
expression was up-regulated on some CD11b expressing
DCs (not shown).
Even in the context of an in vivo viral infection, IPCs
always expressed lower levels of MHC class II and costim-
ulatory molecules than other DCs (Fig. 1 C). In particular,
when we measured cell surface expression of the specific
peptide–MHC class II complexes consisting of HEL-derived
peptide 48–62 bound to I-Ak, by using the monoclonal
antibody Aw3.18, IPCs did not stain, either before or after
in vivo viral stimulation. In contrast, DCs expressed high
levels of specific peptide–MHC complexes (Fig. 1 C). In
agreement with this observation, IL-2 production by the
3A9 hybridoma T cell line, which is activated by as few as
30 peptide-MHC complexes on APC and exhibits a linear
antigen dose response curve between 30 and 200 peptide
MHC complexes, was less efficient when primary IPCs
were used as stimulator as compared with other DCs. In
vitro (Fig. 1 E) or in vivo (Fig. 1 F) stimulation of IPCs
with viruses had no or little effect on IL-2 production,
suggesting that IPC activation does not lead to a cell sur-
face increase of specific peptide–MHC complexes. Simi-
larly, viral stimulation of other DC subsets did not result in
an increased stimulation of IL-2 production. However, in
this case, it is likely that both CD8   and CD11b  DCs
display sufficient peptide–MHC complexes to reach maxi-
mal activation of the 3A9 hybridoma, even in the absence
of stimulation.
All together our data demonstrate that IPCs dramatically
differ from classical DCs in their ability to assemble pep-
tide–MHC class II complexes and to stimulate T cells. In
addition they did not gain this function after in vitro or in
vivo viral stimulation (Fig. 1 C). Similar results were ob-
tained by in vivo injection of LPS and CpG (ODN 1585),
stimuli that markedly enhanced the antigen presenting ca-
pacity of classical DCs (not shown).
Primary IPCs Are Poor Antigen-presenting Cells for Naive
CD8  T Cells. It has been shown that type I IFN pro-
motes survival of CD8  T cells. As IPCs secrete high levels
of type I IFN, they may be specialized in presenting anti-
gen to naive CD8 T cells rather than CD4 T cells. We as-
sessed the ability of IPCs to stimulate CD8 T cells specific
for the male minor transplantation antigen HY, which is
restricted to the MHC H-2Db class I molecule. IPCs and
other DCs were derived from spleens of either uninfected
or VSV-infected male B6 mice. HY-specific CD8  T cells
were prepared from female mice bearing a rearranged  / -
TCR transgene specific for the HY male antigen. As
shown in Fig. 2 A, IPCs were inefficient in inducing prolif-
eration of HY-specific CD8 T cells, as compared with
other DCs. This occurred despite the expression of high
levels of class I molecules on IPCs (Fig. 2 B). Thus, IPCs
are inadequate in presenting antigens to naive CD8 T cells.
DCs Expand Antigen-primed Nonpolarized T Cells which
Proliferate and Produce IFN-  upon Restimulation with IPCs.
DCs not only stimulate naive T cells but also play a key
role in the regulation of CD4 T cell differentiation into
Th1 and Th2 cells (15–17). To compare the capacity of
the different APC subsets to polarize T cell responses,
CD4 T cells derived from 3A9 transgenic mice were co-
cultured with primary DCs purified from mHEL mice.
After 5 to 7 d, T cells expanded by CD8   and CD11b 
DCs were analyzed for their capacity to produce IL-2, IL-4,
and IFN-  at single cell level, by intracellular staining
(Fig. 3 A). IPCs generally failed to expand sufficient num-
bers of T cells for subsequent analysis at this stage. Despite
the high proliferation rate,  70–80% of T cells primed by
classical DCs remained nonpolarized, and still secreted
high amounts of IL-2, as naive T cells. These T cells re-
sponded to CCL19/ELC in transwell migration assays
(Fig. 3 B), expressed both IL-12 receptor (IL-12R)  1 and
 2 chains as well as the specific IL-23R chain and IL-
18R  chain (Fig. 3, C and D), suggesting that they have
lymph node homing capacity and they are prepared to re-
spond to IFN- –inducing cytokines.
To test whether these antigen-experienced but still
largely unpolarized T cells expanded by regular DCs could
further proliferate, and differentiate, thus acquiring effector
function, they were restimulated a second time, using
graded numbers of different APC subsets from the mHEL
mouse. Thymidine incorporation was measured at day 3 af-
ter restimulation. All CD11c  APCs, including IPCs, now
induced rapid division of antigen-primed T cells while
CD11c /CD19  splenic B cells were less effective (Fig. 4
A). T cells restimulated with IPCs and CD8   DCs pro-
Figure 2. Antigen presentation to HY-
specific naive CD8 T cells by HY-transgenic
IPCs and DCs. (A) Proliferation of naive
CD8 T cells (5   104) purified from HY-
transgenic mice to IPCs (open symbols) or
DCs (filled symbols) derived from uninfected
or VSV infected H-2Db B6 males. VSV in-
fection was performed as in Fig. 1. Prolifera-
tion was measured after 72 h. (B) Expression
of H-2Db class I molecules in IPCs or DCs
of uninfected mice (light gray histograms) or
VSV infected mice (dark gray histograms).
Open histograms show staining with a con-
trol antibody. Numbers indicate MFI. T
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903 Krug et al.
duced higher levels of IFN-  as compared with T cells re-
stimulated by CD11b  DCs, which still remained largely
unpolarized (Fig. 4 B), with a small fraction of cells acquir-
ing IL-4 producing capacity. To test whether the Th1 po-
larization induced by IPCs was dependent on the produc-
tion of IL-12, we measured bioactive IL-12 in the
supernatants of preactivated T cell/APC cocultures. Sub-
stantial amounts of IL-12p70 were detected only when
CD8   DCs were used as stimulators (17), indicating that
Th1 polarization induced by IPCs, in these specific culture
conditions, was IL-12 independent.
Recent work has shown that in the mouse as in the hu-
man system, IFN-  production can be elicited through an
IL-12 independent pathway which involves type I IFN
and IL-18 (18, 19). To investigate if Th1 polarization
driven by IPC was mediated by production of type I IFN
and/or IL-18, experiments were performed with neutral-
izing antibodies. A modest reduction in the level of IFN- 
production induced by restimulation with IPCs was de-
tected by neutralizing IL-18 and IFN-  activity (Fig. 5 A).
A direct role of IFN-  in this context could not be deter-
mined because of the lack of good neutralizing reagents
against all mouse IFN-  species. However, we failed to
detect high levels of type I IFN in supernatants of T cell/
IPC cocultures. Neutralizing antibodies to IL-12 effec-
tively reduced the number of IFN-  producing cells in-
duced upon restimulation with CD8   DCs (Fig. 5 A). As
IL-23 has been shown to promote proliferation and IFN- 
production in memory-type and preactivated T cells (20),
we also investigated if IPCs have the intrinsic ability to
produce IL-23. The specific p19 subunit of IL-23, as well
as the IL-12/p35 and the IL-12/IL-23 common p40 sub-
Figure 3. DCs induce expansion of anti-
gen experienced uncommitted T cells
which have lymph node homing potential
and can respond to IFN- –inducing cyto-
kines. (A) CD4  3A9 T cells expanded by
freshly isolated CD11b  or CD8   mHEL
mouse-derived DCs were analyzed for
IFN-  and IL-2 production, 5–7 d after the
first stimulation. (B) In vitro migration to
CCL19 of 3A9 T cells expanded by
CD11b  DCs (black filled symbols) or
CD8   DCs (gray filled symbols) is dose
dependent. (C and D) 3A9 T cells ex-
panded by CD11b  DCs express IL-12,
IL-23, and IL-18 receptors thus having the
capacity to respond to all these IFN- –
inducing cytokines. IL-12R 1, IL-12R 2,
IL-23R, and  -actin were detected by RT-
PCR. (C) Numbers indicate fold dilutions
of cDNAs. IL-12R  ( 1 and  2 chains),
and IL18R  chain expression were measured at the cell surface of 3A9 T cells expanded by CD11b  DCs by flow cytometry at the same time of re-
stimulation. Identical results were obtained with 3A9 T cells expanded by CD8   DCs.
Figure 4. IPCs induce prolif-
eration and IFN-  production
by antigen experienced unpolar-
ized T cells. (A) Proliferative re-
sponse of 3A9 T cells expanded
by CD11b  DCs to graded
numbers of primary unstimu-
lated DCs, IPCs, or B cells. 3A9
T cells were restimulated 9–10 d
after the first stimulation. (B)
IFN-  and IL-4 production in
3A9 T cells restimulated with
primary unstimulated IPCs,
CD8  , and CD11b  DCs. The
percentage of positive cells and
mean fluorescence intensity of
IFN- –producing cells are indi-
cated. (C) Quantitation of IL-
12p70 in supernatants of T cell-
DC and T cell–IPC cocultures.
Supernatants were collected after
24 h and IL-12p70 was measured
by ELISA.T
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904 Interferon-producing Cells Stimulate Memory-type T Cells
unit were amplified from freshly isolated primary IPCs and
from primary IPCs stimulated in vitro for 3 h with CpG
oligonucleotides. As shown in Fig. 5 B, a remarkable in-
duction of p40 and p19 was detectable in CpG-stimulated
IPCs, suggesting that IPCs could represent a major in vivo
source of this cytokine, and indicating that IL-23 may take
part in the IFN-  production observed in IPC-restimu-
lated T cells.
Together, our results indicate that “professional” APCs,
such as DCs, potently stimulate naive T cells and preferen-
tially expand unpolarized T cells at a first encounter. These
antigen-experienced T cells can recirculate to the lymph
node and, during a second antigen encounter, start to ac-
quire T helper commitment. In this context, even “non-
professional APCs,” such as IPCs, may drive proliferation
and rapid differentiation to a Th1 phenotype. At this stage,
the cytokines involved in IFN-  induction are likely to de-
pend on both, the nature of the APC offering the antigen
and its activation state.
Discussion
A systematic analysis of the antigen-presenting function
of distinct murine APC/DC subsets, isolated ex vivo from
the spleen, showed that IPCs were at least 10–50-fold less
efficient than typical DCs in expanding both CD4 and
CD8 naive T cells. In vivo and in vitro stimulation of
IPCs with viruses or CpG oligonucleotides did not signif-
icantly improve their T cell stimulatory capacity, despite
increased cell surface expression of MHC class II and co-
stimulatory molecules. However, IPCs could still present
antigens to antigen-experienced T cells, a cell type less
demanding than virgin T cells, in terms of activation re-
quirements. The intrinsic lack of professionalism in initi-
ating an immune response raises the issue of the DC na-
ture of IPCs. However, the ability to stimulate and
differentiate antigen-primed T cells suggests that IPCs
may indeed exert a more ordinary antigen-presenting
function but still potently modulate and shape immune
responses (1, 2).
Figure 5. Th1 polarization induced by IPCs is IL-12 independent and only partially reverted by neutralizing antibodies to IFN-  and IL-18. (A) IFN- 
and IL-4 production in 3A9 T cells restimulated with freshly isolated unstimulated IPCs or CD8   DCs in the absence or in the presence of neutralizing
antibodies to IFN-  and IL-18R  and/or IL-12. The concomitant neutralization of IFN-  and IL-18 slightly reduce the level of IFN-  production in
T cells restimulated with IPCs; neutralization of IL-12 greatly reduced the number of IFN- –producing cells in T cells restimulated by CD8   DCs.
The percentage of positive cells and mean fluorescence intensity of IFN- –producing cells are indicated. (B) Expression of IL-23p19, IL-12p35, and
IL-12/IL-23p40 common subunit in freshly isolated and CpG (ODN 1826) stimulated IPCs and DCs measured by RT-PCR. Induction of p40 and p19
can be observed in stimulated IPCs.T
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The striking disparity in T cell stimulatory capacity be-
tween IPCs and classical DCs could be the result of differ-
ences in the antigen processing and presenting machinery.
Staining of IPCs and DCs with a monoclonal antibody that
can specifically detect the HEL48–62 peptide/I-Ak com-
plex showed a great discrepancy in the number of com-
plexes displayed at the cell surface of IPCs as compared
with DCs. While HEL antigen was delivered to the plasma
membrane in IPCs, either lack of internalization or insuffi-
cient processing, resulted in low numbers of specific com-
plexes to be assembled. Indeed, human IPCs, have been
shown to express low levels of mature cathepsins (21) and
their antigen-presenting capacity to antigen-specific CD4
or CD8 T cells was comparable to that of a “non-profes-
sional” APCs such as monocytes (not shown). In addition,
capture and uptake of exogenous antigens, via receptor-
mediated endocytosis or macropinocytosis were poorly ac-
complished by human (22–24), as well as mouse primary or
in vitro-derived IPCs (not shown). IPCs were also ineffec-
tive in presenting MHC class I–restricted antigens to naive
CD8 T cells. As the expression of MHC class I molecules
was identical to other DCs, IPCs may be less capable than
DCs in processing and loading stable peptides onto MHC
class I molecules. Proliferation in IPC/T cell cocultures
might also be affected by soluble factors produced by IPCs,
such as type I IFN. However, addition of exogenous IFN- 
to CD4 T cells stimulated by CD11b  DCs, did not result
in inhibition of T cell proliferation (not shown). IPCs in-
ability to stimulate naive T cells could also reflect a lack of
expression of DC specific costimulatory or adhesion mole-
cules essential to trigger naive T cell proliferation.
Professional APCs, such as CD8   and CD8   DCs,
showed a powerful capacity of driving proliferation of na-
ive T cells (7, 25). However, over 80% of these T cells did
not undergo T helper polarization after the first stimula-
tion, preserving the ability to produce high levels of IL-2
typical of naive T cells. These nonpolarized memory type
T cells effectively proliferated and differentiated to IFN- –
producing Th1 cells upon restimulation with CD8   DCs
or IPCs. CD11b  DCs preferentially expanded unpolarized
T cells even after a second round of stimulation.
Recent evidence indicates that a normal immune re-
sponse includes substantial numbers of uncommitted T cells
that produce IL-2 but not IFN- , IL-4, or IL-5 (26). They
seem to provide an expanded pool of antigen-specific T
cells that may differentiate into Th1 or Th2 cells later dur-
ing the primary response or subsequent immune responses,
if needed (26, 27). In addition, they have been shown to
express CCR7, respond to its ligands and thus easily recir-
culate to the lymph nodes, where they can further prolifer-
ate or differentiate (28). Although it has been reported that
TGF-  (26) or brief antigenic stimulation (29), in vitro,
promote expansion of unpolarized T cells, the in vivo
mechanisms regulating the generation of antigen-experi-
enced uncommitted versus Th1/Th2 effector cells are only
partially understood. Our results would suggest that expan-
sion of naive CD4 T cells and acquisition of effector func-
tion could be uncoupled processes, performed, when nec-
essary, by distinct APC types. DCs could accomplish the
difficult task of expanding rare antigen specific T cells.
IPCs, which are likely to be recruited at high numbers to
the lymph node during inflammatory conditions (2), could
rather promote T helper differentiation of antigen-primed
nonpolarized T cells recirculating through high endothelial
venules (HEVs). However, conditions may occur in which
the two functions can be performed by the same APC type.
The Th1 differentiation effect of CD8   DCs during
the second restimulation is dependent on the presence of
IL-12 (30), which in our system, can be secreted by APCs
upon contact with activating T cells via CD40L–CD40 in-
teraction or through cross-linking of other TNF-TNF re-
ceptor superfamily members. On the contrary, IPC–induced
Th1 polarization seems to involve an IL-12–independent
pathway. While IL-18 and IFN-  appear to play a modest
role, other IFN- –inducing cytokines, such as IL-23,
which is indeed produced by CpG-activated IPCs, could
have major effects.
Our results are consistent with the following scenario: T
cells constantly recirculate through a network of APCs in
secondary lymphoid organs (7). During an immune re-
sponse, DCs, which are equipped with an efficient antigen
processing and presenting machinery, can present specific
peptide–MHC complexes and rapidly expand rare antigen-
specific naive T cells. However, only a minor fraction of
these proliferating cells undergo T helper commitment and
reach a mature effector function at a first encounter. Cer-
tain conditions, such as inflammation, may be critical in
promoting the recruitment of other APC subsets, for ex-
ample IPCs, which can deliver differentiation signals to the
proliferating T cells, even in the absence of a second DC–T
cell encounter. As a consequence, the efficiency of T
helper commitment dramatically increases. Uncoupling the
expansion of naive T cells from the acquisition of effector
function provides the immune system with an additional
regulatory checkpoint. This may be helpful in preventing
uncontrolled autoimmune T cell responses and in generat-
ing a pool of sentinel antigen-experienced T cells that
promptly respond to subsequent antigen encounters.
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